Clinical Trials Browser

Multiple Myeloma, Venous Thromboembolism

NCT05920343 2025-07-10

PREVENT-GU

Phase 2/3 Recruiting

120 enrolled

Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Phase 3 Recruiting

1,828 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT06314763 2024-04-30

ROSIE

Phase 4 Completed

21 enrolled

Classical hematologyThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Venous Thromboembolism

NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Phase NA Unknown

320 enrolled

CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

NCT02744092 2023-10-03

CANVAS

Phase NA Completed

811 enrolled 19 charts

Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

NCT03055026 2022-03-11

PRO-LAPSII

Phase 3 Completed

582 enrolled

Classical hematology

Prevention of Venous Thromboembolism

NCT02583191 2021-05-03

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

Phase 3 Terminated

246 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT02746185 2018-08-13

CASTA-DIVA

Phase 3 Completed

159 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

Clinical Trials

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

PREVENT-GU

TRIM-Line

ROSIE

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

CANVAS

PRO-LAPSII

Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients

CASTA-DIVA